MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

SE Ahmadi, S Rahimi, B Zarandi, R Chegeni… - Journal of hematology & …, 2021 - Springer
MYC oncogene is a transcription factor with a wide array of functions affecting cellular
activities such as cell cycle, apoptosis, DNA damage response, and hematopoiesis. Due to …

MYC: connecting selective transcriptional control to global RNA production

TR Kress, A Sabò, B Amati - Nature Reviews Cancer, 2015 - nature.com
Two opposing models have been proposed to describe the function of the MYC oncoprotein
in shaping cellular transcriptomes: one posits that MYC amplifies transcription at all active …

Reflecting on 25 years with MYC

N Meyer, LZ Penn - Nature Reviews Cancer, 2008 - nature.com
Just over 25 years ago, MYC, the human homologue of a retroviral oncogene, was
identified. Since that time, MYC research has been intense and the advances impressive …

JNK signalling in cancer: in need of new, smarter therapeutic targets

C Bubici, S Papa - British journal of pharmacology, 2014 - Wiley Online Library
The JNKs are master protein kinases that regulate many physiological processes, including
inflammatory responses, morphogenesis, cell proliferation, differentiation, survival and …

Apoptosis and cancer: the genesis of a research field

TG Cotter - Nature Reviews Cancer, 2009 - nature.com
In multicellular organisms, the total number of cells is a balance between the cell-generating
effects of mitosis and cell death that is induced through apoptosis. A disruption of this …

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

M Yuneva, N Zamboni, P Oefner… - The Journal of cell …, 2007 - rupress.org
The idea that conversion of glucose to ATP is an attractive target for cancer therapy has
been supported in part by the observation that glucose deprivation induces apoptosis in …

PUMA, a potent killer with or without p53

J Yu, L Zhang - Oncogene, 2008 - nature.com
PUMA (p53 upregulated modulator of apoptosis) is a Bcl-2 homology 3 (BH3)-only Bcl-2
family member and a critical mediator of p53-dependent and-independent apoptosis …

Apoptotic signaling by c-MYC

B Hoffman, DA Liebermann - Oncogene, 2008 - nature.com
Abstract c-MYC has a pivotal function in growth control, differentiation and apoptosis, and its
abnormal expression is associated with many tumors. Overexpression of c-MYC sensitizes …

The circadian clock in cancer development and therapy

L Fu, NM Kettner - Progress in molecular biology and translational …, 2013 - Elsevier
Most aspects of mammalian function display circadian rhythms driven by an endogenous
clock. The circadian clock is operated by genes and comprises a central clock in the brain …

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

MT Hemann, A Bric, J Teruya-Feldstein, A Herbst… - Nature, 2005 - nature.com
The c-Myc oncoprotein promotes proliferation and apoptosis, such that mutations that
disable apoptotic programmes often cooperate with MYC during tumorigenesis. Here we …